[HTML][HTML] Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients

L Passamano, A Taglia, A Palladino, E Viggiano… - Acta …, 2012 - ncbi.nlm.nih.gov
L Passamano, A Taglia, A Palladino, E Viggiano, P D'ambrosio, M Scutifero, MR Cecio…
Acta Myologica, 2012ncbi.nlm.nih.gov
Abstract Duchenne Muscular Dystrophy (DMD) is the most common muscle disease in
children. Historically, DMD results in loss of ambulation between ages 7 and 13 years and
death in the teens or 20s. In order to determine whether survival has improved over the
decades and whether the impact of nocturnal ventilation combined with a better
management of cardiac involvement has been able to modify the pattern of survival, we
reviewed the notes of 835 DMD patients followed at the Naples Centre of Cardiomyology …
Abstract
Duchenne Muscular Dystrophy (DMD) is the most common muscle disease in children. Historically, DMD results in loss of ambulation between ages 7 and 13 years and death in the teens or 20s. In order to determine whether survival has improved over the decades and whether the impact of nocturnal ventilation combined with a better management of cardiac involvement has been able to modify the pattern of survival, we reviewed the notes of 835 DMD patients followed at the Naples Centre of Cardiomyology and Medical Genetics from 1961 to 2006. Patients were divided, by decade of birth, into 3 groups: 1) DMD born between 1961 and 1970; 2) DMD born between 1971 and 1980; 3) DMD born between 1981 and 1990; each group was in turn subdivided into 15 two-year classes, from 14 to 40 years of age. Age and causes of death, type of cardiac treatment and use of a mechanical ventilator were carefully analyzed.
ncbi.nlm.nih.gov